Implementation of Vaccine Manufacturing in Africa

The Partnerships for African Vaccine Manufacturing (PAVM) supported by the Africa Centres for Disease Control and Prevention (Africa CDC) have developed a roadmap and implementation plan for vaccine manufacturing, which was launched in April 2021-the Framework for Action.

Presently, less than one percent of vaccines administered on the continent are manufactured locally. This places a great burden on the health systems of African countries and reduces their ability to respond to pandemics and other health crises.

The overall goal is to enable Africa to manufacture 60 percent of its vaccine needs locally by 2040.

The implementation of these bold programs will be Africa-led, with support from the global system, and will demand that key stakeholders and implementation partners including governments, manufacturers, national regulatory authorities, donors, and funders, work in a coordinated manner.

This workshop session will bring together key stakeholders and collaborators in the Partnerships for African Vaccine Manufacturing (PAVM) Framework for Action to reflect on progress to date and to discuss remaining challenges as part of the ongoing dialogue in the field.

Each speaker will give a short pitch on questions relating to the inter-sectoral collaborations already in place or still required, depending on the area on the roadmap of the Action plan they feel they can best represent.

Participants will include representatives of African manufacturers-to be, Industry, Funders, Market analysts, and Academia, discussing the needs for training and capacity building.

A moderated panel discussion will follow the presentations where the panel members can interact with each other and address questions from the audience.